- Home
- PXLW vs RADX Comparison
PXLW vs RADX Comparison
Compare PXLW & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PXLW
- RADX
- Stock Information
- Founded
- PXLW 1997
- RADX 2021
- Country
- PXLW United States
- RADX Australia
- Employees
- PXLW N/A
- RADX N/A
- Industry
- PXLW Semiconductors
- RADX
- Sector
- PXLW Technology
- RADX
- Exchange
- PXLW Nasdaq
- RADX NYSE
- Market Cap
- PXLW 37.6M
- RADX 32.5M
- IPO Year
- PXLW 2000
- RADX N/A
- Fundamental
- Price
- PXLW $8.98
- RADX $4.25
- Analyst Decision
- PXLW Strong Buy
- RADX Strong Buy
- Analyst Count
- PXLW 2
- RADX 2
- Target Price
- PXLW $15.00
- RADX $13.50
- AVG Volume (30 Days)
- PXLW 78.4K
- RADX 19.3K
- Earning Date
- PXLW 08-06-2025
- RADX 02-26-2025
- Dividend Yield
- PXLW N/A
- RADX N/A
- EPS Growth
- PXLW N/A
- RADX N/A
- EPS
- PXLW N/A
- RADX N/A
- Revenue
- PXLW $34,246,000.00
- RADX $204,609.00
- Revenue This Year
- PXLW $5.21
- RADX N/A
- Revenue Next Year
- PXLW $35.68
- RADX N/A
- P/E Ratio
- PXLW N/A
- RADX N/A
- Revenue Growth
- PXLW N/A
- RADX N/A
- 52 Week Low
- PXLW $4.67
- RADX $3.50
- 52 Week High
- PXLW $14.16
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- PXLW 64.13
- RADX N/A
- Support Level
- PXLW $6.71
- RADX N/A
- Resistance Level
- PXLW $9.92
- RADX N/A
- Average True Range (ATR)
- PXLW 0.55
- RADX 0.00
- MACD
- PXLW 0.14
- RADX 0.00
- Stochastic Oscillator
- PXLW 59.19
- RADX 0.00
About PXLW Pixelworks Inc.
Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.